XML 99 R58.htm IDEA: XBRL DOCUMENT v3.25.0.1
Collaborative Arrangements - Ridgeback Biotherapeutics LP (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 64,168 $ 60,115 $ 59,283
Cost of sales 15,193 16,126 17,411
Selling, general and administrative 10,816 10,504 10,042
Research and development 17,938 30,531 13,548
Accrued and other current liabilities 15,694 15,766  
Ridgeback Biotherapeutics LP | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cost of sales 554 852 3,038
Selling, general and administrative 57 97 147
Research and development 13 60 88
Accrued and other current liabilities 68 113  
Ridgeback Biotherapeutics LP | Lagevrio | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 964 $ 1,428 $ 5,684